SPOTLIGHT: Pfizer top R&D spender worldwide
Pfizer shelled out more on R&D last year than any other company in the world, and drugmakers in general have stepped up their research budgets, the European Commission says. Pfizer spent $8.18 billion, elbowing Ford out of the top slot. Johnson & Johnson came in third. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
